Newborn screening for Duchenne muscular dystrophy in China: follow-up diagnosis and subsequent treatment.

about

Newborn screening for Duchenne muscular dystrophy in China: follow-up diagnosis and subsequent treatment.

Item

http://www.wikidata.org/entity/Q38688284

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Newborn screening for Duchenne ...... osis and subsequent treatment.

@en

type

Item

label

Newborn screening for Duchenne ...... osis and subsequent treatment.

@en

prefLabel

Newborn screening for Duchenne ...... osis and subsequent treatment.

@en

P1476

Newborn screening for Duchenne ...... osis and subsequent treatment.

@en

P2093

Anne Connolly

http://www.w3.org/2001/XMLSchema#string

Arvind Narayana

http://www.w3.org/2001/XMLSchema#string

Daniel Sheehan

http://www.w3.org/2001/XMLSchema#string

Emma Ciafaloni

http://www.w3.org/2001/XMLSchema#string

Jennifer Kwon

http://www.w3.org/2001/XMLSchema#string

Michele Gatheridge

http://www.w3.org/2001/XMLSchema#string

Ming Qi

http://www.w3.org/2001/XMLSchema#string

Peter Sazani

http://www.w3.org/2001/XMLSchema#string

Petra Furu

http://www.w3.org/2001/XMLSchema#string

Qing Ke

http://www.w3.org/2001/XMLSchema#string

P2860

Can outcomes in Duchenne muscular dystrophy be improved by public reporting of data?

Delayed diagnosis in duchenne muscular dystrophy: data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet).

Screening of Duchenne muscular dystrophy (DMD) mutations and investigating its mutational mechanism in Chinese patients.

One year outcome of boys with Duchenne muscular dystrophy using the Bayley-III scales of infant and toddler development.

A comprehensive database of Duchenne and Becker muscular dystrophy patients (0-18 years old) in East China

Screening for inborn errors of metabolism in high-risk children: a 3-year pilot study in Zhejiang Province, China

Practice parameter: corticosteroid treatment of Duchenne dystrophy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.

A mixed methods study of age at diagnosis and diagnostic odyssey for Duchenne muscular dystrophy.

Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management.

Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care.

P2888

s12519-017-0036-3

P304

197-201

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12519-017-0036-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1085103863

http://www.w3.org/2001/XMLSchema#string

P698

28466241

http://www.w3.org/2001/XMLSchema#string